259
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Catha edulis chewing effects on treatment of paranoid schizophrenic patients

&
Pages 1067-1076 | Published online: 15 Apr 2015

References

  • DavisKKahnRSKoGDavidsonMDopamine in schizophrenia: a review and reconceptualizationAm J Psychiatry1991148147414861681750
  • SouhelNDanielMPNeuroinflammation and white matter pathology in schizophrenia: systematic reviewSchizophr Res2015161110211224948485
  • NajjarSPearlmanDMAlperKNajjarADevinskyONeuroinflammation and psychiatric illnessJ Neuroinflammation2013104323547920
  • BanjawMSchmidtWBehavioural sensitization following repeated intermittent oral administration of Catha edulis in ratsBehav Brain Res200515618118915582104
  • BalintEFalkayGBalintGKhat-a controversial plantMiddle Eur J Med2009121604614
  • GoughSPCooksonIBKhat induced schizophreniform psychosis in UK (letter)Lancet1984i455
  • AlemAShibreTKhat induced psychosis and its medico-legal implication: a case reportEthiop Med J1997351371399577014
  • NielenRJvan der HeijdenFMTuinerSVerhoevenWMKhat and mushrooms associated with psychosisWorld J Biol Psychiatry20045495315048636
  • Al HaboriMThe potential adverse effects of habitual use of Catha edulis (khat)Expert Opin Drug Saf200541145115416255671
  • OdenwaldMNeunerFSchauerMKhat use as risk factor for psychotic disorders: a cross-sectional and case–control study in SomaliaBMC Med2005351515707502
  • SchechterMMeehanSMConditioned place preference produced by the psychostimulant cathinoneEur J Pharmacol19932321351388096187
  • Al-HebshiNSkaugNKhat (Catha edulis) – an updated reviewAddict Biol20051029930716318950
  • DaniJAZhouFMSelective dopamine filters of glutamate striatal afferentsNeuron20044252252415157413
  • BaumgartenHGGrozdanovicZPsychopharmacology of central serotonergic systemsPharmacopsychiatry1995273798614704
  • KandelERSchwartzJHJessellTMPrinciple of Neuronal Science4th edNew YorkMcGraw-Hill/Appleton & Lange Companies, Inc2000
  • CalcagnettiDJSchechterMDPlace preference for the psychostimulant-cathinone is blocked by pretreatment with a dopamine release inhibitorProg Neuropsychopharmacol Biol Psychiatry1993176376498103235
  • MeltzerHYLiZKanedaYIchikawaJSerotonin receptors: their key role in drugs to treat schizophreniaProg Neuropsychopharmacol Biol Psychiatry2003271159117214642974
  • NenciniPAhmedAMAmiconiGElmiASTolerance develops to sympathetic effects of khat in humansPharmacology1984281501546718481
  • PehekEASchechterMDYamamotoBKEffects of cathinone and amphetamine on the neurochemistry of dopamine in vivoNeuropharmacology199029117111762293059
  • KalixPThe pharmacology of khatGen Pharmacol1984151791876376274
  • KalixPThe pharmacology of psychoactive alkaloids from Ephedra and CathaJ Ethnopharmacol1991322012081881158
  • FeyissaAMKellyJPA review of the neuropharmacological properties of khatProg Neuropsychopharmacol Biol Psychiatry2008321147116618561890
  • Kotb El-SayedMIAminHAEffect of Catha edulis on insulin, resistin and cortisol levels in type-2 diabetics and non-diabeticsAm J Biochem Biotechnol20128157163
  • RothmanRBRothBLHufeisenSJIn vitro characterization of ephedrine-related stereoisomer at biogenic amine transporters and the receptors revealed selective actions as norepinephrine transporter substratesJ Pharmacol Exp Ther200330713814512954796
  • BanjawMSchmidtWCatha edulis extract and its active principle cathinone induce ipsilateral rotation in unilaterally lesioned ratsBehav Pharmacol20061761562017021394
  • SchotteAJanssenPFMegensAALeysenJEOccupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiographyBrain Res19936311912027510574
  • KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull1987132612763616518
  • World Health OrganizationThe ICD-10 Classification of Mental and Behavioral Disorders-Diagnostic Criteria for ResearchGenevaWHO2010
  • DethySLauteMAVan BlercomNDamhautPGoldmanSHildebrandJMicrodialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patientsClin Chem19974357407449166225
  • GlennonRALiebowitzSMSerotonin receptor affinity of cathinone and related analoguesJ Med Chem1982253933977069716
  • CalcagnettiDJSchechterMDIncrease locomotor activity of rat after intracerebral administration of cathinoneBrain Res Bull1992298438461473016
  • RobinsonTEBeckerJBEnduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosisBrain Res Rev198611157198
  • KalivasPNeurotransmitter regulation of dopamine neurons in the ventral tegmental areaBrain Res Brain Res Rev199318751138096779
  • BanjawMYMiczekKSchmidtWJRepeated Catha edulis oral administration enhances the baseline aggressive behaviour in isolated ratsJ Neural Transm200611354355616082505
  • KrauseKHDreselSHKrauserJKungHFTatschKIncreased striatal dopamine transporter in adult patients with attention deficit hyperactive disorder: effects of methylphenidate as measured by single photon emission computed tomographyNeurosci Lett200028510711010793238
  • KehrJIchinoseFYoshitakeSMephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake ratsBr J Pharmacol20111641949195821615721
  • EllisonGNeural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitryEur Neuropsychopharmacol20021228729712126867
  • ZelgerJSchornoHCarlinEBehavioural effects of cathinone: an amphetamine obtained from Catha edulis: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensineBull Narc19803267816911034
  • PantelisCHindlerCTaylorJUse and abuse of khat (Catha edulis): a review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewingPsychol Med1989196576682572026
  • WarfaNKleinABhuiKLeaveyGCraigTStansfeldSKhat use and mental illness: a critical reviewSoc Sci Med20076530931817544193
  • BhuiKCraigTMohamudSWarfaNStansfeldSAThornicroftGMental disorders among Somali refugees developing culturally appropriate measures and assessing socio-cultural risk factorsSoc Psychiatry Psychiatr Epidemiol20064140040816520881
  • GrazianiMMilellaMNenciniPKhat chewing from the pharmacological point of view: an updateSubst Use Misuse20084376278318473221
  • BarrAMarkouAPhillipsAA‘crash’ course on psychostimulant withdrawal as a model of depressionTrends Pharmacol Sci20022347548212368072
  • ZwebenJCohenJChristianDPsychiatric symptoms in methamphetamine usersAm J Addict20041318119015204668
  • CaiHLFangPLiHDAbnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatmentPsychiatry Res201118819720221146875
  • BennettMROne hundred years of adrenaline: the discovery of autoreceptorsClin Auton Res1999914515910454061
  • FlettJColwellCSerotonin modulation of calcium transients in cells in the suprachiasmatic nucleusJ Biol Rhythms19991435436310511003
  • AronsonJWhere name and image meet″ – the argument for ″adrenalineBr Med J200032050650910678871